FDA Inspection
Biomat USA, Inc.Biomat USA, Inc. – FDA Inspection, Nov 1, 2013
Record Details
This FDA Inspection record concerns Biomat USA, Inc., with an inspection on November 1, 2013, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Biomat USA, Inc.
- Inspection Date
- November 1, 2013
- Product Type
- Biologics
View Company Profile
ID · 77f691e0-1b9c-4218-9e68-c47197be7f7e
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 853846
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
2- 21 CFR 630.40(c)Documentation
- 21 CFR 640.66Procedures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Biomat USA, Inc.
6| Date | Classification | Office | Project area |
|---|---|---|---|
| February 6, 2025 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| July 24, 2019 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| October 14, 2016 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| November 6, 2015 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| April 26, 2012 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Biomat USA, Inc.
- FDA Inspection 1260650 - 2025-02-06
- FDA Inspection 1101254 - 2019-07-24
- FDA Inspection 989349 - 2016-10-14
- FDA Inspection 947931 - 2015-11-06
- FDA Inspection 779415 - 2012-04-26
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.